StemRIM Inc.TSE 4599

株式会社ステムリム · Pharmaceutical · FY ends Jul

Share price at FY-end
—
FY ending Jul 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥112M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 玉井 克人 9,980,000 15.90% — —
2 玉井 佳子 5,400,000 8.60% — —
3 Shionogi Pharmaceutical Co., Ltd. 4,650,000 7.40% — —
4 冨田 憲介 3,830,000 6.10% — —
5 Daisuke Gomi 3,650,000 5.80% — —
6 山﨑 尊彦 2,370,000 3.80% — —
7 みやこ京大イノベーション投資事業有限責任組合 1,943,000 3.10% — —
8 金崎 努 1,538,000 2.50% — —
9 岡島 正恒 1,088,000 1.70% — —
10 株式会社SBI証券 911,000 1.50% — —

Officers' holdings and pay

NameTitleSharesValuePay
岡島 正恒 President & Representative Director, CEO 1,088,700 — ¥142M
玉井 克人 Chairman & Representative Director 9,980,000 — —
澤井 典子 Director 3,000 — —
永井 宏忠 Director 3,000 — —
久渡 庸二 Full-time Audit & Supervisory Board Member 136,000 — —
水上 亮比呂 Audit & Supervisory Board Member 71,500 — —
島田 洋一郎 Audit & Supervisory Board Member 46,500 — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Jul 2026 — ¥-29.63 — — 62,681,200
FY ending Jul 2025 — ¥-31.16 — — 62,136,200
Source: annual securities reports on EDINET. Values are estimates. Methodology